Actively Recruiting
Digital Lifestyle Intervention for Lung Cancer Survivors
Led by Kai-Uwe Schmitt, PhD, MEng, ICID · Updated on 2025-01-30
88
Participants Needed
4
Research Sites
126 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to assess the efficacy of a digital lifestyle intervention in non-small cell lung cancer (NSCLC) survivors on health-related quality of life (HRQoL) over three months.
CONDITIONS
Official Title
Digital Lifestyle Intervention for Lung Cancer Survivors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosis of non-small cell lung cancer (NSCLC)
- Estimated life expectancy of 6 months or more (judged by local health professionals)
- Undergoing inpatient or outpatient rehabilitation OR completed planned surgery, chemotherapy, or radiation therapy for NSCLC within the past 24 weeks
- Ability to understand German for study materials and assessments
- Access to a cell phone or tablet
- Provided written informed consent
You will not qualify if you...
- Unable to provide informed consent
- Unable to participate in the intervention due to physical, cognitive, or safety reasons (judged by local health professionals)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Klinik Barmelweid AG
Barmelweid, Switzerland, 5017
Actively Recruiting
2
Zürcher RehaZentren | Klinik Davos
Davos, Switzerland, 7272
Actively Recruiting
3
Berner Reha Zentrum AG
Heiligenschwendi, Switzerland, 3625
Actively Recruiting
4
Zürcher RehaZentren | Klinik Wald
Wald, Switzerland, 8636
Actively Recruiting
Research Team
A
Anja Frei, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here